Life Science Reit Plc (GB:LABS)
LSE:LABS
LABS Stock Chart & Stats
39.10 p
-0.10 p(-0.28%)
At close: 4:00 PM EST
39.10 p
-0.10 p(-0.28%)
Day’s Range― - ―
52-Week Range34.00 p - 49.00 p
Previous CloseN/A
Volume38.03K
Average Volume (3M)1.26M
Market Cap
£141.40M
Enterprise Value263.08M
Total Cash (Recent Filing)£4.72M
Total Debt (Recent Filing)£126.40M
Price to Earnings (P/E)―
Beta0.52
Next Earnings
Sep 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding350,000,000
10 Day Avg. Volume565,873
30 Day Avg. Volume1,260,832
Financial Highlights & Ratios
PEG Ratio0.27
Price to Book (P/B)0.51
Price to Sales (P/S)6.55
P/FCF Ratio-20.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.02
Revenue Forecast (FY)£23.93M
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetA debt-free balance sheet provides financial stability and flexibility, allowing the company to invest in growth opportunities without the burden of interest payments.
High Occupancy RatesHigh occupancy rates driven by strategic partnerships enhance revenue stability and reduce vacancy risks, supporting long-term cash flow and profitability.
Industry DemandGrowing demand in the life sciences sector supports long-term leasing opportunities, ensuring sustained revenue growth and market relevance.
Bears Say
Declining RevenueDeclining revenue indicates challenges in maintaining market share and customer base, potentially impacting long-term financial health and growth prospects.
Negative ProfitabilityNegative profitability reflects operational inefficiencies and challenges in cost management, which can hinder the company's ability to generate sustainable profits.
Negative Free Cash FlowNegative free cash flow suggests difficulties in managing capital expenditures and funding operations, potentially limiting growth and investment capabilities.
Life Science Reit Plc News
LABS FAQ
What was Life Science Reit Plc’s price range in the past 12 months?
Life Science Reit Plc lowest share price was 34.00 p and its highest was 49.00 p in the past 12 months.
What is Life Science Reit Plc’s market cap?
Life Science Reit Plc’s market cap is £141.40M.
When is Life Science Reit Plc’s upcoming earnings report date?
Life Science Reit Plc’s upcoming earnings report date is Sep 17, 2026 which is in 160 days.
How were Life Science Reit Plc’s earnings last quarter?
Currently, no data Available
Is Life Science Reit Plc overvalued?
According to Wall Street analysts Life Science Reit Plc’s price is currently Overvalued.
Does Life Science Reit Plc pay dividends?
Life Science Reit Plc pays a Semiannually dividend of 1 p which represents an annual dividend yield of N/A. See more information on Life Science Reit Plc dividends here
What is Life Science Reit Plc’s EPS estimate?
Life Science Reit Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Life Science Reit Plc have?
Life Science Reit Plc has 350,000,000 shares outstanding.
What happened to Life Science Reit Plc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Life Science Reit Plc?
Currently, no hedge funds are holding shares in GB:LABS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Life Science Reit Plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
Life Science Reit Plc
Life Science Reit Plc is an investment company, which intends to carry on business as a REIT. Its objective is to provide Shareholders with an attractive level of total return. The company was founded on July 27, 2021 and is headquartered in London, the United Kingdom.
Technical Analysis
Derwent London plc REIT
―
Great Portland Estates plc R.E.I.T.
―
Primary Health Properties plc R.E.I.T
―
Segro plc (REIT)
―
Workspace Group plc R.E.I.T.
―
Options Prices
Currently, No data available
---